Vor Biopharma (VOR) Other Working Capital Changes (2020 - 2026)
Vor Biopharma's (VOR) quarterly Other Working Capital Changes came in at -$61000.0 in Q1 2026, up 94.18% year-on-year from -$31414.3 in Q1 2025, and down 3.39% on a QoQ basis from -$59000.0 in Q4 2025.
Vor Biopharma (VOR) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of Other Working Capital Changes data on file, last reported at -$61000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 94.18% year-over-year to -$61000.0 in Q1 2026; TTM through Mar 2026 was -$1.4 million, a 64.14% increase from a year earlier, with the FY2025 full-year figure at -$2.4 million, up 37.18% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$61000.0, down from -$59000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for VOR reached as high as $3.4 million in Q3 2023 and fell as low as -$2.6 million in Q2 2025.
- Historically, Other Working Capital Changes has averaged $49000.0 across 5 years, with a median of -$7000.0 in 2023.
- Across the five-year window, Other Working Capital Changes plunged 4443.75% in 2022 and surged 97.93% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$1.4 million in 2022, then surged by 33.87% to -$937000.0 in 2023, then fell by 9.28% to -$1.0 million in 2024, then soared by 94.24% to -$59000.0 in 2025, then retreated by 3.39% to -$61000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$61000.0 in Q1 2026, -$59000.0 in Q4 2025, and -$20000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vor Biopharma | 187.37 Mn | 187.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61,000.00 |
| Mar 31, 2026 | -61,000.00 |
| Mar 31, 2026 | -61,000.00 |
| Dec 31, 2025 | -59,000.00 |
| Dec 31, 2025 | -59,000.00 |
| Dec 31, 2025 | -59,000.00 |
| Sep 30, 2025 | -20,000.00 |
| Sep 30, 2025 | -20,000.00 |
| Sep 30, 2025 | -20,000.00 |
| Jun 30, 2025 | -1.28 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Mar 31, 2025 | -1.05 Mn |
| Mar 31, 2025 | -1.05 Mn |
| Mar 31, 2025 | -1.05 Mn |
| Dec 31, 2024 | -1.02 Mn |
| Dec 31, 2024 | -1.02 Mn |
| Dec 31, 2024 | -1.02 Mn |
| Sep 30, 2024 | -966,000.00 |
| Sep 30, 2024 | -966,000.00 |